0followers
2005founded
About ALLOZYNE INC
Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week.
Source: Wikipedia
IndustryBiotechnology
HeadquartersSeattle, WA
Founded2005
Legal formC Corporation
StatusActive
Reviews
No reviews yet. Worked with ALLOZYNE INC? Be the first to share your experience.
Key figures
Sign in to see the key figures
Revenue, net income and head count of ALLOZYNE INC over the years, with their sources.
Sign in Create an account with your emailIt's free
By continuing, you agree to Heelky's User Agreement, Privacy Policy and Cookie Policy.
Legal information
| Legal name | ALLOZYNE INC |
|---|---|
| Legal form | C Corporation |
| SEC CIK | 1345630View on SEC EDGAR ↗ |
| Registered address | Seattle, WA |
| Status | Active |
Sources: SEC EDGAR · updated Nov. 14, 2026
Contact & links
Location
Seattle, WA
Is this your company?
Claim this page for free to add your logo, products, photos and jobs, and to answer reviews.
Claim this pageJoin Heelky to connect, hire and grow
Create a free account to message people, apply to jobs and post missions.
Join now — it's free